Genetic Links to Episodic Movement Disorders: Current Insights

Area of Science:

• Neurology
• Genetics
• Movement Disorders

Background:

• Episodic or paroxysmal movement disorders (PxMD) are transient hyperkinetic conditions with normal interictal periods.
• These disorders include paroxysmal dyskinesias and episodic ataxias, traditionally classified clinically.
• Advancements in genetics reveal phenotypic pleiotropy and necessitate a new classification paradigm based on molecular pathogenesis.

Purpose of the Study:

• To review the evolving classification of PxMD based on molecular pathogenesis.
• To highlight the advantages of a genetic paradigm in identifying treatable PxMD.
• To discuss the current understanding and future directions in PxMD research.

Main Methods:

• Review of current literature on PxMD classification and genetics.
• Analysis of molecular pathogenesis categories including synaptopathies, channelopathies, and others.
• Discussion of genetic clues for primary etiology and network involvement.

Main Results:

• PxMD are now categorized based on molecular pathogenesis (e.g., channelopathies, synaptopathies).
• Genetic insights identify treatable disorders like GLUT1 deficiency and ADCY5-related disorders.
• Key etiological clues include early onset, family history, and fixed triggers.

Conclusions:

• A molecular pathogenesis-based classification is crucial for understanding PxMD.
• Genetics aids in identifying treatable PxMD, improving patient outcomes.
• Next-generation sequencing advances PxMD research, though genetic underpinnings of some entities remain unknown.